Skip to content
Menu

Maze Therapeutics, Inc. MAZE

Full chart Compare
Set alert

Price alert · MAZE

All alert types
32.43 USD +1.23 (+3.94%)

Regular-session close

32.46 +0.03 +0.09%

After hours · Nov 19, 7:43 PM ET

30.69 Day range 32.74
21.95 52-week range 53.65
YTD
-21.72%
1 year
-8.75%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$167.50MNet Income$52.23MSelling, General & Admin$26.42MResearch & Development$83.50MOther Expenses$4.18MIncome Tax$1.17MRevenue$167.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

MAZE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-142.90M57.59M-98.55M-111.03M
-131.12M3.40M-100.42M-114.94M
-3.051.25-43.89-5.93
MAZE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
190.34M197.90M30.25M101.13M
397.13M240.54M71.50M149.96M
42.16M43.64M61.45M48.51M
23.31M26.63M49.62M32.05M
354.97M-311.18M-373.85M-282.46M
MAZE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-111.94M75.95M-86.83M-99.20M
-170.96M-1.15M-441.00K-3.17M
275.34M92.85M16.39M1.73M
-794.00K-1.15M-441.00K-1.97M
-7.57M167.65M-70.88M-100.64M